Platinum Cuts

Oxford Endovascular Ltd is a pioneering medical device company focused on preventing brain hemorrhages by treating brain aneurysms, a condition affecting 1 in 50 people. The company has developed OxiFlow, a next-generation flow diverter that safely diverts blood flow away from aneurysms, significantly reducing the risk of complications and making more patients treatable. Founded as a spinout from Oxford University, Oxford Endovascular has raised over £10 million to support its innovative solutions and has garnered recognition in the MedTech industry, including winning the Best Medtech Video award at the MedTech Innovator finals. With a team of experienced professionals, the company is poised to address unmet clinical needs in a rapidly growing market valued at over £1 billion. Generated from the website